It's a moment of pride for Fesarius as we celebrate Dr. Jason Spector's latest breakthrough in tissue engineering. His relentless pursuit of innovation has led to significant advancements in regenerative medicine, impacting countless lives. Congratulations, Dr. Spector, on your unwavering commitment to excellence and your continuous contributions to the medical field. Your work not only embodies the spirit and culture here at FesariusTx, but also sets a benchmark for healthcare innovation worldwide. 🔬🩺 🌟 #Innovation #Healthcare #TissueEngineering #FesariusTherapeutics #FesariusTx
FesariusTherapeutics
Biotechnology
NY, New York 462 followers
A cutting-edge NY-based biotech start-up on a mission to revolutionize the world of regenerative medicine.
About us
FesariusTherapeutics - the cutting-edge biotech start-up on a mission to revolutionize the world of regenerative medicine. We are dedicated to developing innovative tissue-engineered products to transform reconstructive and aesthetic surgery. Based upon technology spun-out from The Laboratory for Bioregenerative Medicine and Surgery at Weill Cornell Medicine, FesariusTherapeutics has developed DermiSphere, a revolutionary dermal regeneration template (DRT) for the management of wounds.
- Website
-
http://www.fesariustherapeutics.com
External link for FesariusTherapeutics
- Industry
- Biotechnology
- Company size
- 2-10 employees
- Headquarters
- NY, New York
- Type
- Privately Held
- Founded
- 2015
- Specialties
- Material Science, Tissue Reconstruction, Wound Healing, Collagen, and Medical Devices
Locations
-
Primary
Get directions
NY, New York, US
Employees at FesariusTherapeutics
-
Tom Roueche
Accomplished Corporate Development Professional and Early Stage Enthusiast
-
Brett Spector
Co-founded machine learning hedge fund t24 Capital LLC and FesariusTherapeutics Inc., maker of DermiSphere(tm)
-
Yulia Sapir-Lekhovitser
Chief Scientific Officer and Co-Founder at FesariusTherapeutics
-
Derek Luong, Ph.D.
Research Scientist at FesariusTherapeutics
Updates
-
So proud of this team! Enjoying some well deserved down time after filing the Company’s first 510K FDA submission the night before!! 3 years of grit and determination is now coming to fruition as Fesarius looks to improve the lives of so many patients dealing with debilitating full thickness skin loss. Next up, marketing authorization and patient #1.
-